Christopher A Lamb - Concepedia

Author

Christopher A Lamb

Newcastle University ORCID

Also Known As

BSG IBD Section members, C A Lamb, C Lamb, C. A Lamb, C. A. LAMB, C. A. Lamb, C. Lamb, C.A. Lamb, CA Lamb, Chris A Lamb

209

Publications

9.4K

Citations

H-Index

107

Concepts

All Affiliations

Newcastle University Newcastle upon Tyne Hospitals NHS Foundation Trust King's College London Western General Hospital St Mark's Hospital

About

Christopher A Lamb is an author at Newcastle University specializing in medicine, immunology, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	1.1K
2	Cell Biology	4	4	228
3	Public Health	3	3	111
4	Allergy	2	2	47
5	Health Sciences	1	1	61

Christopher A Lamb

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial Séverine Vermeire, Sharon O’Byrne, Mary Keir, The Lancet	2014	449
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD Nicholas A. Kennedy, Simeng Lin, James Goodhand, Gut	2021	275
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic Nicholas A. Kennedy, Gareth‐Rhys Jones, Christopher A Lamb, Gut	2020	255
Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis A Masi, Nicholas D. Embleton, Christopher A Lamb, Gut	2020	205
Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7 Yang Luo, Katrina M. de Lange, Luke Jostins, Nature Genetics Autoimmune DiseaseGenetic EpidemiologyGastroenterologyPathologyImmunology	2017	174
Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility Aleksejs Sazonovs, Christine Stevens, Guhan Venkataraman, Nature Genetics Genome-wide Association StudyDisease SusceptibilityAutoimmune DiseaseRare VariantsImmunology	2022	174
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Nicholas A. Kennedy, James Goodhand, Claire Bewshea, Edinburgh Research Explorer (University of Edinburgh)	2021	163
Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis Gaik W. Tew, Jason A. Hackney, Deena L. Gibbons, Gastroenterology	2015	153
Strain-specific impacts of probiotics are a significant driver of gut microbiome development in very preterm infants Lauren C. Beck, A Masi, Gregory R. Young, Nature Microbiology	2022	148
Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease Christopher A Lamb, Mohammed Khaliq Mohiuddin, J Gicquel, British journal of surgery	2009	133

Page 1